AeroFact
Development- Indications
- Neonatal Respiratory Distress Syndrome
Company intelligence / Profile preview
Nuance’s healthcare AI solutions are widely adopted in the U.S. and globally, with over 550,000 clinicians using their products across more than 10,000 healthcare organizations. Their cloud-based speech recognition tools are used in 77% of U.S. hospitals and by over half of all physicians and radiologists in the country. The company’s platforms have been recognized as industry leaders for accuracy and efficiency in medical documentation but do not conduct drug development or clinical trials.
No traditional “clinical results” apply since they provide digital health infrastructure rather than therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nuance Communications.